AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$2.16
+0.04 (+1.89%)
Open$2.21
Previous Close$2.12
Day High$2.21
Day Low$2.13
52W High$3.07
52W Low$1.65
Volume—
Avg Volume23.8K
Market Cap21.14M
P/E Ratio—
EPS$-4.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+323.6% upside
Current
$2.16
$2.16
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 105.43M | 119.52M | 4.25M |
| Net Income | -21,539,380 | -21,976,467 | 1.24M |
| Profit Margin | -20.4% | -19.4% | 29.2% |
| EBITDA | -6,581,699 | -7,088,327 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -11.8% | -11.8% | +20.1% |
| Debt/Equity | 1.15 | 1.15 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |